Literature DB >> 29593093

TAILS N-terminomics and proteomics reveal complex regulation of proteolytic cleavage by O-glycosylation.

Sarah L King1, Christoffer K Goth1, Ulrich Eckhard2, Hiren J Joshi1, Amalie D Haue1, Sergey Y Vakhrushev1, Katrine T Schjoldager1, Christopher M Overall3, Hans H Wandall4.   

Abstract

Proteolytic processing is an irreversible post-translational modification functioning as a ubiquitous regulator of cellular activity. Protease activity is tightly regulated via control of gene expression, enzyme and substrate compartmentalization, zymogen activation, enzyme inactivation, and substrate availability. Emerging evidence suggests that proteolysis can also be regulated by substrate glycosylation and that glycosylation of individual sites on a substrate can decrease or, in rare cases, increase its sensitivity to proteolysis. Here, we investigated the relationship between site-specific, mucin-type (or GalNAc-type) O-glycosylation and proteolytic cleavage of extracellular proteins. Using in silico analysis, we found that O-glycosylation and cleavage sites are significantly associated with each other. We then used a positional proteomic strategy, terminal amine isotopic labeling of substrates (TAILS), to map the in vivo cleavage sites in HepG2 SimpleCells with and without one of the key initiating GalNAc transferases, GalNAc-T2, and after treatment with exogenous matrix metalloproteinase 9 (MMP9) or neutrophil elastase. Surprisingly, we found that loss of GalNAc-T2 not only increased cleavage, but also decreased cleavage across a broad range of other substrates, including key regulators of the protease network. We also found altered processing of several central regulators of lipid homeostasis, including apolipoprotein B and the phospholipid transfer protein, providing new clues to the previously reported link between GALNT2 and lipid homeostasis. In summary, we show that loss of GalNAc-T2 O-glycosylation leads to a general decrease in cleavage and that GalNAc-T2 O-glycosylation affects key regulators of the cellular proteolytic network, including multiple members of the serpin family.
© 2018 King et al.

Entities:  

Keywords:  GalNAc-T2; Proteolytic processing; glycobiology; metalloprotease; post-translational modification (PTM); protease inhibitor; proteomics; serine protease; terminomics

Mesh:

Substances:

Year:  2018        PMID: 29593093      PMCID: PMC5961060          DOI: 10.1074/jbc.RA118.001978

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing.

Authors:  Katrine Ter-Borch Gram Schjoldager; Malene B Vester-Christensen; Christoffer K Goth; Thomas Nordahl Petersen; Søren Brunak; Eric P Bennett; Steven B Levery; Henrik Clausen
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.

Authors:  Weston R Gould; Jay R Silveira; Paula B Tracy
Journal:  J Biol Chem       Date:  2003-10-31       Impact factor: 5.157

3.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

4.  Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.

Authors:  Katrine T Schjoldager; Hiren J Joshi; Yun Kong; Christoffer K Goth; Sarah Louise King; Hans H Wandall; Eric P Bennett; Sergey Y Vakhrushev; Henrik Clausen
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

Review 5.  Ectodomain shedding and ADAMs in development.

Authors:  Silvio Weber; Paul Saftig
Journal:  Development       Date:  2012-10       Impact factor: 6.868

Review 6.  New approaches for dissecting protease functions to improve probe development and drug discovery.

Authors:  Edgar Deu; Martijn Verdoes; Matthew Bogyo
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

7.  Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells.

Authors:  Sarah L King; Hiren J Joshi; Katrine T Schjoldager; Adnan Halim; Thomas D Madsen; Morten H Dziegiel; Anders Woetmann; Sergey Y Vakhrushev; Hans H Wandall
Journal:  Blood Adv       Date:  2017-02-23

8.  Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis.

Authors:  Tim J Wigle; Laurel M Provencher; Jacqueline L Norris; Jian Jin; Peter J Brown; Stephen V Frye; William P Janzen
Journal:  Chem Biol       Date:  2010-07-30

9.  Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis.

Authors:  S J Duguay; Y Jin; J Stein; A N Duguay; P Gardner; D F Steiner
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Three types of low density lipoprotein receptor-deficient mutant have pleiotropic defects in the synthesis of N-linked, O-linked, and lipid-linked carbohydrate chains.

Authors:  D M Kingsley; K F Kozarsky; M Segal; M Krieger
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

View more
  8 in total

Review 1.  G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications.

Authors:  Christoffer K Goth; Ulla E Petäjä-Repo; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-17

2.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 3.  Neutrophil Elastase and Chronic Lung Disease.

Authors:  Judith A Voynow; Meagan Shinbashi
Journal:  Biomolecules       Date:  2021-07-21

4.  Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.

Authors:  Earnest James Paul Daniel; Matilde Las Rivas; Erandi Lira-Navarrete; Ana García-García; Ramon Hurtado-Guerrero; Henrik Clausen; Thomas A Gerken
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

5.  O-glycan initiation directs distinct biological pathways and controls epithelial differentiation.

Authors:  Ieva Bagdonaite; Emil Mh Pallesen; Zilu Ye; Sergey Y Vakhrushev; Irina N Marinova; Mathias I Nielsen; Signe H Kramer; Stine F Pedersen; Hiren J Joshi; Eric P Bennett; Sally Dabelsteen; Hans H Wandall
Journal:  EMBO Rep       Date:  2020-04-23       Impact factor: 8.807

Review 6.  Towards structure-focused glycoproteomics.

Authors:  Anastasia Chernykh; Rebeca Kawahara; Morten Thaysen-Andersen
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

7.  Protein cleavage influences surface protein presentation in Mycoplasma pneumoniae.

Authors:  Iain J Berry; Michael Widjaja; Veronica M Jarocki; Joel R Steele; Matthew P Padula; Steven P Djordjevic
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.379

8.  Reg-1α, a New Substrate of Calpain-2 Depending on Its Glycosylation Status.

Authors:  Marie-Christine Lebart; Françoise Trousse; Gilles Valette; Joan Torrent; Morgane Denus; Nadine Mestre-Frances; Anne Marcilhac
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.